CODX vs JCI · rev $3.9M vs P/E 44, rev $23.60B
Co-Diagnostics, Inc. Common Stock (CODX) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
CODX currently screens at market cap $31.4M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the CODX and JCI stock pages for the full models.
Not investment advice.